Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.21
-0.08-6.2%
Last update: Oct 16, 5:21 PM
$1.23
-0.06-4.65%
PMV Pharmaceuticals Inc (PMVP) Stock Price, Quote, News & History
PMVPNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PMV Pharmaceuticals (NASDAQ:PMVP) through any online brokerage.
Other companies in PMV Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
PMV Pharmaceuticals has a consensus price target of $5.17.
The stock price for PMV Pharmaceuticals (NASDAQ: PMVP) is $1.23 last updated October 16, 2026 at 5:21 PM EDT.
There are no upcoming dividends for PMV Pharmaceuticals.
PMV Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for PMV Pharmaceuticals.
PMV Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
